FMC Technologies (FTI) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

19.02.26 15:30 Uhr

Werte in diesem Artikel
Aktien

14,43 EUR -0,56 EUR -3,70%

38,70 EUR 0,10 EUR 0,26%

61,33 EUR 1,35 EUR 2,25%

Indizes

PKT PKT

1.978,4 PKT -10,8 PKT -0,54%

2.039,6 PKT -11,5 PKT -0,56%

23.168,1 PKT -130,8 PKT -0,56%

8.634,5 PKT -67,5 PKT -0,78%

1.814,0 PKT -25,7 PKT -1,40%

2.975,3 PKT 0,8 PKT 0,03%

2.143,9 PKT 0,6 PKT 0,03%

219,4 PKT 0,3 PKT 0,14%

609,5 PKT -2,7 PKT -0,44%

12.265,4 PKT -73,6 PKT -0,60%

23.213,0 PKT -95,0 PKT -0,41%

23.146,7 PKT -107,5 PKT -0,46%

8.944,7 PKT -54,0 PKT -0,60%

16.328,5 PKT 0,0 PKT 0,00%

1.854,4 PKT -8,4 PKT -0,45%

FMC Technologies (FTI) reported $2.52 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 6.3%. EPS of $0.70 for the same period compares to $0.54 a year ago.The reported revenue represents a surprise of -1.17% over the Zacks Consensus Estimate of $2.55 billion. With the consensus EPS estimate being $0.51, the EPS surprise was +36.77%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how FMC Technologies performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Inbound Orders - Subsea Technologies: $2.34 billion compared to the $2.45 billion average estimate based on 13 analysts.Order Backlog - Subsea Technologies: $15.87 billion versus $16.31 billion estimated by 13 analysts on average.Order Backlog - Total: $16.57 billion versus $17.06 billion estimated by 11 analysts on average.Order Backlog - Surface Technologies: $699.9 million compared to the $728.81 million average estimate based on 11 analysts.Inbound Orders - Surface Technologies: $247.7 million compared to the $276.42 million average estimate based on 11 analysts.Inbound Orders - Total: $2.59 billion versus $2.74 billion estimated by 11 analysts on average.Book-to-bill - Subsea: 1 versus 1 estimated by 11 analysts on average.Revenue- Surface Technologies: $322.8 million compared to the $322 million average estimate based on 14 analysts. The reported number represents a change of +1.1% year over year.Revenue- Subsea Technologies: $2.19 billion versus $2.23 billion estimated by 14 analysts on average. Compared to the year-ago quarter, this number represents a +7.1% change.Adjusted EBITDA- Subsea: $415.6 million versus $420.64 million estimated by 14 analysts on average.Adjusted EBITDA- Surface Technologies: $58.2 million versus the 14-analyst average estimate of $52.5 million.Adjusted EBITDA- Corporate Expenses: $-34.2 million compared to the $-35.54 million average estimate based on 11 analysts.View all Key Company Metrics for FMC Technologies here>>>Shares of FMC Technologies have returned +14.9% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report TechnipFMC plc (FTI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: FMC und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: Zacks

Nachrichten zu Fresenius Medical Care (FMC) St.

Analysen zu Fresenius Medical Care (FMC) St.

DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St KaufenDZ BANK
03.12.2025Fresenius Medical Care (FMC) St BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
07.11.2025Fresenius Medical Care (FMC) St BuyGoldman Sachs Group Inc.
05.11.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
15.08.2025Fresenius Medical Care (FMC) St KaufenDZ BANK
DatumRatingAnalyst
12.03.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
02.03.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
27.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
25.02.2026Fresenius Medical Care (FMC) St HoldDeutsche Bank AG
24.02.2026Fresenius Medical Care (FMC) St Equal WeightBarclays Capital
DatumRatingAnalyst
13.03.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
10.03.2026Fresenius Medical Care (FMC) St SellUBS AG
02.03.2026Fresenius Medical Care (FMC) St UnderperformJefferies & Company Inc.
25.02.2026Fresenius Medical Care (FMC) St UnderweightJP Morgan Chase & Co.
24.02.2026Fresenius Medical Care (FMC) St SellUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen